## Abstract A series of azaaromatic quaternary ammonium analogues, e.g. (I) and (II), is discovered as potent and selective Ξ±9Ξ±10 nicotinic acetylcholine receptor (nAChR) antagonists.
Neuronal nicotinic acetylcholine receptors as a target for the treatment of neuropathic pain
β Scribed by Michael D. Meyer
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 102 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Neuronal nicotinic acetylcholine receptor (nAChR) agonists have been demonstrated to exhibit antinociceptive, antihyperalgesic, and antiallodynic effects across a range of preclinical models of pain. Yet, to date, no drugs have been successfully developed and approved for the treatment of pain from this pharmacological class. In this overview, the mechanism and site of action of nAChR agonists in models of neuropathic pain, as well as the current status and future prospects for the development of drugs from this class for the treatment of neuropathic pain, will be discussed. Drug Dev. Res. 67:355β359, 2006. Β© 2006 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract Several pathologies related to nervous tissue alterations are characterized by a chronic pain syndrome defined by persistent or paroxysmal pain independent or dependent on a stimulus. Pathophysiological mechanisms related to neuropathic disease are associated with mitochondrial dysfunct
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
## Abstract Noradrenaline (NA), released in association with sympathetic nerve sprouting into the dorsal root ganglion (DRG) after peripheral nerve injury, may enhance neuropathic pain. ATP serves as a pain mediator; however, NAβregulated ATP mobilizations in the DRG is far from understanding. In t